A senior European Medicines Agency official has highlighted how the nine-month-old Accelerating Clinical Trials in the EU (ACT EU) initiative could serve as a platform to address the challenges clinical trial sponsors face in complying with EU data privacy requirements in the General Data Protection Regulation (GDPR).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?